Studies for Long COVID Treatments Are Finally Getting Underway
The National Institutes of Health is beginning a handful of studies to test possible treatments for long COVID, an anxiously awaited step in U.S. efforts against the mysterious condition that afflicts millions.
Monday’s announcement from the NIH’s $1.15 billion RECOVER project comes amid frustration from patients who’ve struggled for months or even years with sometimes-disabling health problems — with no proven treatments and only a smattering of rigorous studies to test potential ones.
[time-brightcove not-tgx=”true”]
“This is a year or two late and smaller in scope than one would hope but nevertheless it’s a step in the right direction,” said Dr. Ziyad Al-Aly of Washington University in St. Louis, who isn’t involved with NIH’s project but whose own research highlighted long COVID’s toll. Getting answers is critical, he added, because “there’s a lot of people out there exploiting patients’ vulnerability” with unproven therapies.
Scientists don’t yet know what causes long COVID, the catchall term for about 200 widely varying symptoms. Between 10% and 30% of people are estimated to have experienced some form of long COVID after recovering from a coronavirus infection, a risk that has dropped somewhat since early in the pandemic.
“If I get 10 people, I get 10 answers of what long COVID really is,” U.S. Health and Human Services Secretary ...
Source: TIME: Health - Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 wire Source Type: news
More News: Biology | Brain | Chronic Fatigue Syndrome | Coronavirus | COVID-19 | Education | Harvard | Health | Medical Devices | National Institutes of Health (NIH) | Neurology | Pandemics | Pfizer | Science | Sleep Disorders | Sleep Medicine | Sports Medicine | Study | Training | Universities & Medical Training | Washington University